One case–control study conducted among 611 lung cancer cases and 1040 controls in Los Angeles found elevated lung cancer risk associated with the variant genotype of TP53 rs2078486 SNP (doctoral dissertation from Yi Ren Wang) [11]. This evidence concerns the gene TP53 and lung carcinoma.